Track the 지더블유바이텍 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 지더블유바이텍 has published 62 insider filings. The latest transaction was disclosed on 20 December 2024 (Purchase). Among the most active insiders: 백옥생코리아. All data is free.
62
Insider Decl.
n/a
Thresholds
n/a
22 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
지더블유바이텍 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.